IFN-gamma downregulates interleukin-4 functional activity on monocytes by multiple mechanisms

Area of Science:

• Immunology
• Cell Biology
• Cytokine Signaling

Background:

• Interleukin-4 (IL-4) exhibits anti-inflammatory effects on monocytes, suppressing the production of tumor necrosis factor-alpha (TNF-alpha) and IL-1beta induced by lipopolysaccharide (LPS).
• Interferon-gamma (IFN-gamma) is known to modulate monocyte responses, influencing the actions of other cytokines.

Purpose of the Study:

• To investigate the mechanisms by which IFN-gamma alters human monocyte responses to IL-4.
• To characterize the opposing effects of type 1 (IFN-gamma) and type 2 (IL-4) cytokine regulatory systems on monocyte function.

Main Methods:

• Human monocytes were cultured with IFN-gamma and subsequently treated with IL-4.
• Analysis included assessment of IL-4-activated signal transducer and activator of transcription-6 (STAT-6) activation.
• Monocyte responses to LPS-induced cytokine production (TNF-alpha, IL-1beta) and IL-4 receptor (IL-4R) expression were measured.

Main Results:

• IFN-gamma reduced IL-4-induced STAT-6 activation, correlating with impaired IL-4-mediated suppression of LPS-induced TNF-alpha production.
• A delayed effect of IFN-gamma involved significant suppression of IL-4R surface expression, leading to loss of IL-4's ability to suppress IL-1beta production.
• IFN-gamma treatment increased the release of soluble gammac from monocytes, suggesting another mechanism for controlling IL-4 activity.

Conclusions:

• IFN-gamma significantly impacts IL-4 function in human monocytes through multiple mechanisms, including reduced STAT-6 activation and IL-4R expression.
• The increased release of soluble gammac by IFN-gamma-treated monocytes provides an additional pathway for IFN-gamma to regulate IL-4's anti-inflammatory effects.
• This study further elucidates the complex interplay between type 1 and type 2 cytokines in regulating immune cell responses.